SurgaColl Holdings Ltd announces Series A funding successfully closed
10th January, 2018
SurgaColl technologies Ltd has completed a corporate restructuring and established a UK based holding company, SurgaColl Holdings Ltd and closed a £3.1m funding round led by Catapult Ventures (see detail below). The funds will be used to continue clinical evidence development,product development and building a world class team.
SurgaColl Technologies: Board announcement – appointment of CEO
16th January, 2017
The Board of SurgaColl Technologies Ltd, the developer of innovative collagen based products for the regeneration of human tissue, announces the appointment of William (Bill) Allan as Chief Executive Officer with immediate effect.